144 related articles for article (PubMed ID: 11231770)
21. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma.
Seregard S; Oskarsson M; Spångberg B
Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1451-8. PubMed ID: 8641848
[TBL] [Abstract][Full Text] [Related]
22. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma.
Lake SL; Kalirai H; Dopierala J; Damato BE; Coupland SE
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2647-52. PubMed ID: 22427594
[TBL] [Abstract][Full Text] [Related]
23. [THE BRAF MUTATION AND THE POSSIBILITIES OF UVEAL MELANOMA METASTASING PROGNOSTIC MARKERS IDENTIFICATION].
Horkovičová K; Markus J; Krčová I; Babál P; Kobzová D; Smolková B
Cesk Slov Oftalmol; 2016; 72(4):149-156. PubMed ID: 27860480
[TBL] [Abstract][Full Text] [Related]
24. Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma.
de Lange MJ; Nell RJ; Lalai RN; Versluis M; Jordanova ES; Luyten GPM; Jager MJ; van der Burg SH; Zoutman WH; van Hall T; van der Velden PA
Mol Cancer Res; 2018 Dec; 16(12):1902-1911. PubMed ID: 30093564
[TBL] [Abstract][Full Text] [Related]
25. Discrepancy between fluorescence in situ hybridization and multiplex ligation-dependent probe amplification in orbital recurrence of uveal melanoma 26 years after enucleation.
Russo A; Rene C; Coupland SE; Sagili S; Damato B
Ophthalmic Plast Reconstr Surg; 2012; 28(6):e140-2. PubMed ID: 22460679
[TBL] [Abstract][Full Text] [Related]
26. Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors.
Jha J; Singh MK; Singh L; Pushker N; Bajaj MS; Sen S; Kashyap S
Int J Clin Oncol; 2019 Dec; 24(12):1526-1535. PubMed ID: 31377937
[TBL] [Abstract][Full Text] [Related]
27. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss.
Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory cell infiltrates in advanced metastatic uveal melanoma.
Krishna Y; McCarthy C; Kalirai H; Coupland SE
Hum Pathol; 2017 Aug; 66():159-166. PubMed ID: 28655639
[TBL] [Abstract][Full Text] [Related]
29. Correlation of Immunocytochemistry of BRCA1-associated Protein-1 (BAP1) With Other Prognostic Markers in Uveal Melanoma.
Glasgow BJ; McCannel TA
Am J Ophthalmol; 2018 May; 189():122-126. PubMed ID: 29530782
[TBL] [Abstract][Full Text] [Related]
30. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma.
Fuchs U; Kivelä T; Summanen P; Immonen I; Tarkkanen A
Am J Pathol; 1992 Jul; 141(1):169-81. PubMed ID: 1378696
[TBL] [Abstract][Full Text] [Related]
31. Lack of BRAF mutation in primary uveal melanoma.
Cohen Y; Goldenberg-Cohen N; Parrella P; Chowers I; Merbs SL; Pe'er J; Sidransky D
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2876-8. PubMed ID: 12824225
[TBL] [Abstract][Full Text] [Related]
32. High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients.
Laurent C; Valet F; Planque N; Silveri L; Maacha S; Anezo O; Hupe P; Plancher C; Reyes C; Albaud B; Rapinat A; Gentien D; Couturier J; Sastre-Garau X; Desjardins L; Thiery JP; Roman-Roman S; Asselain B; Barillot E; Piperno-Neumann S; Saule S
Cancer Res; 2011 Feb; 71(3):666-74. PubMed ID: 21135111
[TBL] [Abstract][Full Text] [Related]
33. Heat shock protein expression in the eye and in uveal melanoma.
Missotten GS; Journée-de Korver JG; de Wolff-Rouendaal D; Keunen JE; Schlingemann RO; Jager MJ
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3059-65. PubMed ID: 12824252
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of legumain in uveal melanoma.
Wu T; Sun L; Wu Y; Xiang R; Li Y; Rong W; Sun F; Wang N
Mol Med Rep; 2016 Mar; 13(3):2377-84. PubMed ID: 26846877
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
[TBL] [Abstract][Full Text] [Related]
36. Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.
Triozzi PL; Elson P; Aldrich W; Achberger S; Tubbs R; Biscotti CV; Singh AD
Melanoma Res; 2013 Feb; 23(1):1-7. PubMed ID: 23196330
[TBL] [Abstract][Full Text] [Related]
37. Two Distinct Uveal Melanomas in the Same Eye.
Nissen EJ; Kalirai H; Damato B; Heimann H; Coupland SE
JAMA Ophthalmol; 2015 Sep; 133(9):1094-6. PubMed ID: 26110363
[No Abstract] [Full Text] [Related]
38. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
39. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas.
Ma D; Niederkorn JY
Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1067-75. PubMed ID: 9620065
[TBL] [Abstract][Full Text] [Related]
40. GDF11 upregulation independently predicts shorter overall-survival of uveal melanoma.
Liu X; Zhang Q; Fan C; Tian J; Liu X; Li G
PLoS One; 2019; 14(3):e0214073. PubMed ID: 30883611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]